{
    "organizations": [],
    "uuid": "5784844d8ffbbe89832e897d9b6cf472c0e6fa69",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neuland-laboratories-says-nclt-app/brief-neuland-laboratories-says-nclt-approved-scheme-of-amalgamation-between-co-neuland-health-sciences-neuland-pharma-research-idUSFWN1RA0EM",
    "ord_in_thread": 0,
    "title": "BRIEF-Neuland Laboratories Says ‚ÄçNCLT Approved Scheme Of Amalgamation Between Co, Neuland Health Sciences, Neuland Pharma Research",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Neuland Laboratories Ltd:\n* NCLT, HYDERABAD BENCH, APPROVED SCHEME OF AMALGAMATION BETWEEN CO, NEULAND HEALTH SCIENCES, NEULAND PHARMA RESEARCH Source text - bit.ly/2pMc2jy Further company coverage:\n ",
    "published": "2018-03-28T19:20:00.000+03:00",
    "crawled": "2018-03-29T15:25:49.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "neuland",
        "laboratory",
        "ltd",
        "nclt",
        "hyderabad",
        "bench",
        "approved",
        "scheme",
        "amalgamation",
        "co",
        "neuland",
        "health",
        "science",
        "neuland",
        "pharma",
        "research",
        "source",
        "text",
        "company",
        "coverage"
    ]
}